Page last updated: 2024-10-28

guanethidine and Keratoconus

guanethidine has been researched along with Keratoconus in 1 studies

Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.

Keratoconus: A noninflammatory, usually bilateral protrusion of the cornea, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. The cause is unknown but hereditary factors may play a role. The -conus refers to the cone shape of the corneal protrusion. (From Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonnet, M1
Lemarchands, H1
Martin, J1

Other Studies

1 other study available for guanethidine and Keratoconus

ArticleYear
[Prevention and treatment of the "irreducible mydriasis--progressive atrophy of the iris" syndrome following perforating keratoplasty for keratoconus].
    Annales d'oculistique, 1969, Volume: 202, Issue:11

    Topics: Acetylcholine; Anesthetics, Local; Atrophy; Atropine; Eye Diseases; Eye Injuries; Guanethidine; Huma

1969